Ardent Health (NYSE:ARDT) Announces Earnings Results

Ardent Health (NYSE:ARDT) posted its quarterly earnings results on Wednesday. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.08, FiscalAI reports. The business had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.60 billion. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.

Ardent Health Trading Up 17.5%

Shares of NYSE:ARDT traded up $2.27 during midday trading on Thursday, reaching $15.27. 928,327 shares of the company’s stock were exchanged, compared to its average volume of 457,062. The stock has a market cap of $2.15 billion, a price-to-earnings ratio of 27.74, a P/E/G ratio of 3.31 and a beta of 0.58. Ardent Health has a fifty-two week low of $7.71 and a fifty-two week high of $16.23. The firm’s 50 day simple moving average is $11.22 and its two-hundred day simple moving average is $10.02. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Weiss Ratings upgraded shares of Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, October 6th. Guggenheim raised their target price on Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Royal Bank Of Canada boosted their price target on Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Truist Financial increased their price objective on Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Finally, Wall Street Zen lowered Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Ardent Health presently has a consensus rating of “Hold” and a consensus target price of $12.79.

About Ardent Health

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.